FDA expected to authorize Pfizer's Covid vaccine for teens ages 12-15 by next WEEK
- Food and Drug Administration is preparing to authorize Pfizer's Covid vaccine for people ages 12-5, officials told the New York Times
- Authorization is expected to come as early as late this week, or early next week
- The Pfizer vaccine was authorized for anyone aged 16 or older in the U.S. in December
- A trial conducted from October to March found that Pfizer's shot was 100% effective at preventing severe illness or death in 12- to 15-year-olds
- However, less than 0.1 percent of all U.S. Covid fatalities were in kids under 18, raising questions about whether kids will be getting shots just to protect adults U.S. regulators are expected green light Pfizer's Covid vaccine to be given to teenagers between ages 12 and 15 as early as the end of this week, officials told the New York Times.
The shot was authorized for people ages 16 and up in December, and Pfizer has been in trials for teens since October of last year.
Expanding the trial to younger teenagers will make about 13 million additional Americans eligible for vaccination, a step that some see as critical to reaching herd immunity and improving safety as children return to school.
Others, however, have questioned whether vaccinating children is worth the risk, considering that only 471 children under age 18 have died of COVID-19, accounting for 0.1 percent of all U.S. coronavirus fatalities.
Authorization could be given as early as the end of this week, and is expected by early next week.
U.S. regulators are expected green light Pfizer's Covid vaccine to be given to teenagers between ages 12 and 15 as early as the end of this week, officials told the New York Times
No comments: